To establish whether our findings in the PKCα-KR CLL-like model were applicable to primary human CLL samples, we treated human CLL cells with IB or Enza in the presence of F(ab’)2 stimulation (BCR-XL) and assessed the phosphorylation/activation status of BTK. The gene discussed is BTK; the disease is B-cell chronic lymphocytic leukemia.